Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Pediatr. 2021 Mar 24;234:236–244.e2. doi: 10.1016/j.jpeds.2021.03.028

Table 6:

Staphylococcus aureus (SA) vs Streptococcus pyogenes (GAS)

Characteristic SA (N=228) GAS(N=21)
N Median (IQR) N Median (IQR)
Age at admission (yrs) 228 8.80 (3.60, 11.60) 21 6.10 (2.90, 7.80)
Female, n (%) 228 76 (33%) 21 10 (48%)
Duration of hospitalization (days) 228 7.00 (5.00, 10.50) 21 4.00 (3.00, 8.00)
Total (IV + PO) duration of antibiotic treatment (days) 227 42.00 (31.00, 52.00) 21 36.00 (29.00, 47.00)
Peak CRP (mg/L) during hospitalization 228 158.00 (76.00, 245.00) 21 129.00 (62.00, 184.00)
Peak WBC count (*103) during hospitalization 222 13.00 (10.00, 17.00) 21 14.00 (12.00, 22.00)
Peak ESR (mm/hr) during hospitalization 202 65.50 (38.00, 88.00) 19 57.00 (44.00, 80.00)
Infection Type, n (%)
 Both 228 76 (33%) 21 5 (24%)
 Osteomyelitis 228 127 (56%) 21 7 (33%)
 Septic Arthritis 228 25 (11%) 21 9 (43%)
Bacteremia, n (%) 214 156 (73%) 18 7 (39%)
Persistent bacteremia (>72 h), n (%) 214 52 (24%) 18 0 (0%)
Surgery performed, n (%) 228 187 (82%) 21 18 (86%)
ICU required, n (%) 228 41 (18%) 21 4 (19%)
PO therapy at discharge, n (%) 228 135 (59%) 21 15 (71%)
Function at end of therapy, n (%)
 Cast 185 4 (2%) 19 0 (0%)
 Full ROM 185 151 (82%) 18 16 (89%)
Pain at end of therapy, n (%)
 None 185 135 (73%) 19 17 (89%)
 Mild 185 43 (23%) 19 2 (11%)
 Moderate 185 7 (4%) 19 0 (0%)
Pathologic fracture, n (%) 225 12 (5%) 21 0 (0%)
Concern for recurrence of infection/treatment failure, n (%) 225 26 (12%) 21 1 (5%)